Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCD-115 in ER+/HER2- Advanced Breast Cancer
NCT03065010Phase 1Completed
- Sponsor
- BIOCAD
- Start
- Nov 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of senexin b in breast cancer, sponsored by BIOCAD. Primary endpoints: Area under the plasma concentration versus time curve at 90 days, Peak Plasma Concentration at 90 days and 2 more. Started Nov 2016; status: completed.
02
Drugs
senexin b
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03065010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03065010.